Healthcare provider profile · identity verified

Jacob Wayne Helsel, DO

Internal Medicine · MORGANTOWN, WV · NPI 1568099513

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	673	80
Levothyroxine Sodium	Levothyroxine Sodium	498	82
Atorvastatin Calcium	Atorvastatin Calcium	482	137
Furosemide	Furosemide	410	92
Eliquis	Apixaban	379	68
Pantoprazole Sodium	Pantoprazole Sodium	360	103
Tamsulosin Hcl	Tamsulosin Hcl	222	66
Sertraline Hcl	Sertraline Hcl	219	53
Metoprolol Succinate	Metoprolol Succinate	210	78
Amlodipine Besylate	Amlodipine Besylate	192	56
Divalproex Sodium	Divalproex Sodium	182	53
Trazodone Hcl	Trazodone Hcl	179	46
Metformin Hcl	Metformin Hcl	178	42
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	162	30
Clonazepam	Clonazepam	150	16
Prednisone	Prednisone	150	77
Mirtazapine	Mirtazapine	149	44
Lisinopril	Lisinopril	147	49
Januvia	Sitagliptin Phosphate	144	25
Buspirone Hcl	Buspirone Hcl	139	40
Metoprolol Tartrate	Metoprolol Tartrate	137	50
Carvedilol	Carvedilol	134	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	132	22
Tramadol Hcl	Tramadol Hcl	127	36
Potassium Chloride	Potassium Chloride	125	43
Oxycodone Hcl	Oxycodone Hcl	124	35
Clopidogrel	Clopidogrel Bisulfate	119	47
Famotidine	Famotidine	113	35
Duloxetine Hcl	Duloxetine Hcl	111	26
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	109	79
Arexvy	Rsvpref3 Antigen/As01e/Pf	109	109
Losartan Potassium	Losartan Potassium	109	37
Quetiapine Fumarate	Quetiapine Fumarate	98	25
Levetiracetam	Levetiracetam	96	25
Escitalopram Oxalate	Escitalopram Oxalate	89	25
Jardiance	Empagliflozin	81	14
Bumetanide	Bumetanide	80	32
Donepezil Hcl	Donepezil Hcl	80	24
Cefdinir	Cefdinir	78	51
Olanzapine	Olanzapine	78	20
Lacosamide	Lacosamide	77	suppressed
Alprazolam	Alprazolam	74	suppressed
Aripiprazole	Aripiprazole	73	14
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	73	27
Risperidone	Risperidone	73	17
Doxycycline Hyclate	Doxycycline Hyclate	72	56
Pregabalin	Pregabalin	72	14
Citalopram Hbr	Citalopram Hydrobromide	71	17
Lactulose	Lactulose	71	14
Xarelto	Rivaroxaban	70	13
Baclofen	Baclofen	63	suppressed
Ondansetron Hcl	Ondansetron Hcl	61	26
Fluticasone Propionate	Fluticasone Propionate	60	30
Phenobarbital	Phenobarbital	60	suppressed
Torsemide	Torsemide	59	13
Nystop	Nystatin	58	38
Lamotrigine	Lamotrigine	56	12
Tradjenta	Linagliptin	55	suppressed
Finasteride	Finasteride	54	14
Ropinirole Hcl	Ropinirole Hcl	51	15
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	50	23
Isosorbide Mononitrate Er	Isosorbide Mononitrate	49	19
Rosuvastatin Calcium	Rosuvastatin Calcium	49	26
Carbidopa-Levodopa	Carbidopa/Levodopa	48	14
Fluoxetine Hcl	Fluoxetine Hcl	48	12
Nifedipine Er	Nifedipine	48	24
Nystatin	Nystatin	47	27
Hydralazine Hcl	Hydralazine Hcl	45	13
Tizanidine Hcl	Tizanidine Hcl	45	13
Entresto	Sacubitril/Valsartan	44	13
Insulin Lispro Kwikpen U-100	Insulin Lispro	43	23
Ezetimibe	Ezetimibe	42	suppressed
Ozempic	Semaglutide	42	suppressed
Allopurinol	Allopurinol	41	15
Oxybutynin Chloride	Oxybutynin Chloride	41	12
Spironolactone	Spironolactone	41	24
Cefuroxime	Cefuroxime Axetil	38	30
Sucralfate	Sucralfate	37	15
Farxiga	Dapagliflozin Propanediol	36	13
Hydroxyzine Pamoate	Hydroxyzine Pamoate	36	suppressed
Latanoprost	Latanoprost	36	16
Novolog Flexpen	Insulin Aspart	36	12
Oxcarbazepine	Oxcarbazepine	36	suppressed
Omeprazole	Omeprazole	35	19
Simvastatin	Simvastatin	35	suppressed
Memantine Hcl	Memantine Hcl	34	11
Amiodarone Hcl	Amiodarone Hcl	33	15
Linzess	Linaclotide	33	suppressed
Montelukast Sodium	Montelukast Sodium	33	15
Brilinta	Ticagrelor	32	13
Morphine Sulfate Er	Morphine Sulfate	31	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	30	11
Paxlovid	Nirmatrelvir/Ritonavir	30	30
Lantus	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Cephalexin	Cephalexin	28	22
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Lorazepam	Lorazepam	28	19
Midodrine Hcl	Midodrine Hcl	28	13
Ondansetron Odt	Ondansetron	27	suppressed
Pravastatin Sodium	Pravastatin Sodium	27	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	25	19
Doxepin Hcl	Doxepin Hcl	25	suppressed
Myrbetriq	Mirabegron	25	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	24	suppressed
Methocarbamol	Methocarbamol	24	13
Linezolid	Linezolid	23	14
Meloxicam	Meloxicam	23	suppressed
Tresiba Flextouch U-100	Insulin Degludec	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	12
Breyna	Budesonide/Formoterol Fumarate	22	12
Nitroglycerin	Nitroglycerin	22	19
Topiramate	Topiramate	22	suppressed
Albuterol Sulfate	Albuterol Sulfate	21	14
Alendronate Sodium	Alendronate Sodium	21	suppressed
Incruse Ellipta	Umeclidinium Bromide	21	suppressed
Klayesta	Nystatin	21	20
Phenytoin Sodium Extended	Phenytoin Sodium Extended	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Veltassa	Patiromer Calcium Sorbitex	21	suppressed
Budesonide	Budesonide	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Ceftriaxone	Ceftriaxone Sodium	19	14
Enoxaparin Sodium	Enoxaparin Sodium	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Metronidazole	Metronidazole	18	11
Morphine Sulfate	Morphine Sulfate	18	18
Vraylar	Cariprazine Hcl	18	suppressed
Azithromycin	Azithromycin	17	13
Benztropine Mesylate	Benztropine Mesylate	17	suppressed
Carbamazepine	Carbamazepine	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Levofloxacin	Levofloxacin	17	16
Metformin Hcl Er	Metformin Hcl	17	suppressed
Primidone	Primidone	17	suppressed
Xtampza Er	Oxycodone Myristate	17	suppressed
Amantadine	Amantadine Hcl	16	suppressed
Megestrol Acetate	Megestrol Acetate	16	suppressed
Procrit	Epoetin Alfa	16	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	16	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	12
Fluconazole	Fluconazole	15	11
Rasagiline Mesylate	Rasagiline Mesylate	15	suppressed
Tiotropium Bromide	Tiotropium Bromide	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Belsomra	Suvorexant	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Calcium Acetate	Calcium Acetate	14	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Lidocaine Hcl	Lidocaine Hcl	13	13
Nuplazid	Pimavanserin Tartrate	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Aptiom	Eslicarbazepine Acetate	12	suppressed
Atenolol	Atenolol	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Arformoterol Tartrate	Arformoterol Tartrate	11	suppressed
Carbidopa-Levodopa-Entacapone	Carbidopa/Levodopa/Entacapone	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error